Pfizer's COVID-19 vaccine is reportedly being flown by United Airlines chartered flights to distribution hubs, in anticipation of FDA approval
United Airlinesflights from Brussels to Chicago are carrying Pfizer's COVID-19 vaccine, according to The Wall Street Journal.
- The flights represent one leg of a chain, which will extend from Chicago to distribution hubs around the US.
- Pfizer's vaccine must be stored in -103 degrees Fahrenheit, so the flights reportedly have special
FAAapproval to carry 15,000 pounds of dry ice.
As drugmaker Pfizer seeks regulatory approval for its
The Federal Aviation Administration (FAA) approved the shipments, which require the vaccine candidate to be packed in dry ice, according to CNN."As a result of the historic pace of vaccine development through Operation Warp Speed and careful logistics planning, the FAA today is supporting the first mass air shipment of a vaccine," the agency said in a statement Friday.
Pfizer, along with its German partner BioNTech, announced in early November that its vaccine was more than 90% effective in a clinical study. But it's just one of several being developed in a global scramble to end the Coronavirus pandemic.Another vaccine from the University of Oxford and drugmaker AstraZeneca was later found to be 70% effective, although AstraZeneca acknowledged a mistake in the dosages during trials. And Moderna's vaccine has been found to be 94.5% effective in a trial, the company said this week.
Now, even before the US Food and Drug Administration and other government agencies issue approvals, supply chains are being put in place to get each vaccine to communities around the world. Pfizer's vaccine candidate has its own shipping challenges, partly because it must be stored at a very low temperature, about -94 degrees Fahrenheit. Dry ice usually is limited on flights, but United got FAA approval to car about 15,000 pounds of it for each flight, according to the WSJ report.Meanwhile, in the UK, some NHS hospital staff have reportedly been told to expect vaccine doses to be distributed by as early as December 7. It's expected that frontline workers, including hospital staff, will be among the first to receive doses after government approvals. Last Monday, the Medicines and Healthcare Regulatory Agency confirmed it was working through data from Pfizer and BioNTech's vaccine study. The agency didn't release a timeline for approval, but said it "will aim to make a decision in the shortest time possible," according to a release.
"It is our job now to rigorously assess these data and the evidence submitted on the vaccine's safety, quality and effectiveness," June Raine, MHRA's chief executive, said in a statement.
- Infosys had a great year but CEO Salil Parekh expects the next one to be more than twice as good
- Infosys will buy back shares at ₹1,750 — more than what some analysts had expected
- Best broadband plans in India in 2021 – JioFiber, Airtel Xstream Fiber and ACT Fibernet
- IPL 2021: Royal Challengers Bangalore have beaten Sunrisers Hyderabad 7 out of 18 times they played each other
- Publicis Groupe consolidates Data Science, Programmatic and Media Tech with Zenith and Starcom, under a common leadership